Jennifer Michaelson, Chief Scientific Officer at Cullinan Therapeutics, Inc. (CGEM), sold 11,742 shares at $13.62 ($165K) on 2026-02-20, disclosed to the SEC on 2026-02-23.
Seasonal sale ($165k) by Chief Scientific Officer — this insider has traded CGEM in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.62 | 3,742 | $51K | 30.8% |
| 2 | $14.30 | 8,000 | $114K | 69.2% |
| Total | $14.08 avg | 11,742 | $165K | 100% |
| Filing → |
| CGEM | SELL | 2026-07-07 | $143K | — | Filing → |
| CGEM | SELL | 2026-05-06 | $117K | — | Filing → |
| CGEM | SELL | 2026-03-09 | $125K | — | Filing → |